Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.

Massai R, Mäkäräinen L, Kuukankorpi A, Klipping C, Duijkers I, Dieben T.

Hum Reprod. 2005 Oct;20(10):2764-8. Epub 2005 Jun 24.

PMID:
15980008
2.

Outcome after a high number (4-10) of repeated caesarean sections.

Juntunen K, Mäkäräinen L, Kirkinen P.

BJOG. 2004 Jun;111(6):561-3.

3.

Can the reproducibility of fetal heart rate baseline estimation be improved?

Ayres-de-Campos D, Bernardes J, Marsal K, Nickelsen C, Makarainen L, Banfield P, Xavier P, Campos I.

Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15;112(1):49-54.

PMID:
14687738
4.

Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.

Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, Hout J, Bennink HC.

Hum Reprod. 2000 Jan;15(1):118-22.

PMID:
10611199
5.

The pharmacodynamics and efficacy of Implanon. An overview of the data.

Croxatto HB, Mäkäräinen L.

Contraception. 1998 Dec;58(6 Suppl):91S-97S. Retraction in: Rekers H, Affandi B. Contraception. 2004 Nov;70(5):433.

PMID:
10095979
6.

Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.

Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H.

Fertil Steril. 1998 Apr;69(4):714-21.

PMID:
9548163
7.
9.

Can progestin be limited to every third month only in postmenopausal women taking estrogen?

Hirvonen E, Salmi T, Puolakka J, Heikkinen J, Granfors E, Hulkko S, Mäkäräinen L, Nummi S, Pekonen F, Rautio AM, et al.

Maturitas. 1995 Jan;21(1):39-44.

PMID:
7731382
10.

Aggressive direct treatment of a fetus with supraventricular tachycardia and hydrops fetalis.

Jouppila P, Mäkäräinen L, Räsänen J, Valkama M, Paavilainen T.

Ultrasound Obstet Gynecol. 1993 Jul 1;3(4):279-83.

11.

Endobrush sampling for endometrial cancer.

Vuopala S, Klemi PJ, Mäenpää J, Salmi T, Mäkäräinen L.

Acta Obstet Gynecol Scand. 1989;68(4):345-50.

PMID:
2618622
12.

Tiaprofenic acid in the treatment of primary dysmenorrhoea.

Kauppila A, Mäkilä UM, Mäkäräinen L, Puolakka J, Seppälä A.

Eur J Obstet Gynecol Reprod Biol. 1986 Sep;22(5-6):359-63.

PMID:
3533672
13.

Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen.

Mäkäräinen L, Ylikorkala O.

Br J Obstet Gynaecol. 1986 Sep;93(9):974-8.

PMID:
3533137
14.

Ibuprofen prevents IUCD-induced increases in menstrual blood loss.

Mäkäräinen L, Ylikorkala O.

Br J Obstet Gynaecol. 1986 Mar;93(3):285-8.

PMID:
3516203
15.

Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors.

Puolakka J, Mäkäräinen L, Viinikka L, Ylikorkala O.

J Reprod Med. 1985 Mar;30(3):149-53.

PMID:
3839018
16.

Amniotic fluid 6-keto-prostaglandin F1 alpha and thromboxane B2 during labor.

Mäkäräinen L, Ylikorkala O.

Am J Obstet Gynecol. 1984 Nov 15;150(6):765-8.

PMID:
6388335
17.

Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin.

Mäkäräinen L, Ylikorkala O.

Br J Obstet Gynaecol. 1983 Jun;90(6):570-2.

PMID:
6134549
18.

Hormonal and metabolic effects of intravenous infusion of prostacyclin in healthy women.

Ylikorkala O, Knip M, Mäkäräinen L, Pakarinen A, Viinikka L.

Acta Endocrinol (Copenh). 1982 Nov;101(3):468-71.

PMID:
6756011
19.

Lack of effect of circulating prostacyclin on contractility of the non-pregnant human uterus.

Mäkäräinen L, Ylikorkala O.

Br J Obstet Gynaecol. 1982 May;89(5):402-7.

PMID:
7044406
20.

Prostacyclin production increases during human parturition.

Ylikorkala O, Mäkäräinen L, Viinikka L.

Br J Obstet Gynaecol. 1981 May;88(5):513-6.

PMID:
7016168

Supplemental Content

Loading ...
Support Center